FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570201758> ?p ?o ?g. }

• W1570201758 endingPage "341" @default.
• W1570201758 startingPage "326" @default.
• W1570201758 abstract "The XIENCE V® Everolimus-Eluting Coronary Stent System (EECSS) has been evaluated in multiple randomized controlled trials (RCTs) with several different comparators (SPIRIT FIRST, SPIRIT II, SPIRIT III, SPIRIT IV, COMPARE, ISAR-TEST 4, SORT-OUT IV, and RESOLUTE All-Comers RCT). The available results consistently demonstrated numerically low stent thrombosis (ST) rates in the XIENCE V arm treated patients. The use of XIENCE V in complex patients with diabetes, overlapping stents, multistenting, and other known risk factors has not significantly increased the occurrence of ST, as evident in the 2-year rates of both per protocol and Academic Research Consortium (ARC)-defined ST rates in the SPIRIT IV RCT, as well as the COMPARE real-world RCT. Furthermore, available long-term follow-up in the SPIRIT FIRST, SPIRIT II, and SPIRIT III RCTs showed continued numerically low very late ST rates as well. High compliance rates of dual antiplatelet therapy (DAPT) were observed in the SPIRIT trials, which may have contributed to consistently numerically low ST rates in the XIENCE V arm treated patients. Several potential risk factors for developing ST may well have been minimized through the selective XIENCE V thin strut design, biocompatible polymers, and antiproliferative drug usage. (J Interven Cardiol 2011;24:326-341)." @default.
• W1570201758 created "2016-06-24" @default.
• W1570201758 creator A5020132420 @default.
• W1570201758 creator A5037790670 @default.
• W1570201758 creator A5039632207 @default.
• W1570201758 creator A5060436966 @default.
• W1570201758 creator A5072690690 @default.
• W1570201758 creator A5073630551 @default.
• W1570201758 creator A5078396173 @default.
• W1570201758 creator A5090480235 @default.
• W1570201758 date "2011-03-28" @default.
• W1570201758 modified "2023-09-26" @default.
• W1570201758 title "Low Stent Thrombosis Risk with the XIENCE V® Everolimus-Eluting Coronary Stent: Evidence from Randomized and Single-Arm Clinical Trials" @default.
• W1570201758 cites W101302537 @default.
• W1570201758 cites W105018345 @default.
• W1570201758 cites W117883744 @default.
• W1570201758 cites W1433020779 @default.
• W1570201758 cites W1482026388 @default.
• W1570201758 cites W1527614413 @default.
• W1570201758 cites W1799423166 @default.
• W1570201758 cites W1968528328 @default.
• W1570201758 cites W1969118708 @default.
• W1570201758 cites W1986421604 @default.
• W1570201758 cites W1988072208 @default.
• W1570201758 cites W1989556574 @default.
• W1570201758 cites W1991022286 @default.
• W1570201758 cites W1993222177 @default.
• W1570201758 cites W1997207240 @default.
• W1570201758 cites W1999359428 @default.
• W1570201758 cites W2009589924 @default.
• W1570201758 cites W2009920921 @default.
• W1570201758 cites W2018956552 @default.
• W1570201758 cites W2028204364 @default.
• W1570201758 cites W2036113234 @default.
• W1570201758 cites W2037810462 @default.
• W1570201758 cites W2039010543 @default.
• W1570201758 cites W2047021474 @default.
• W1570201758 cites W2049120615 @default.
• W1570201758 cites W2052106438 @default.
• W1570201758 cites W2057218988 @default.
• W1570201758 cites W2061556888 @default.
• W1570201758 cites W2061975208 @default.
• W1570201758 cites W2065396486 @default.
• W1570201758 cites W2070725184 @default.
• W1570201758 cites W2071545961 @default.
• W1570201758 cites W2074934448 @default.
• W1570201758 cites W2075528363 @default.
• W1570201758 cites W2080978991 @default.
• W1570201758 cites W2083630382 @default.
• W1570201758 cites W2084529035 @default.
• W1570201758 cites W2086599873 @default.
• W1570201758 cites W2087150869 @default.
• W1570201758 cites W2087641863 @default.
• W1570201758 cites W2089313624 @default.
• W1570201758 cites W2096769223 @default.
• W1570201758 cites W2100113253 @default.
• W1570201758 cites W2100654828 @default.
• W1570201758 cites W2103766009 @default.
• W1570201758 cites W2107406419 @default.
• W1570201758 cites W2112494872 @default.
• W1570201758 cites W2119470649 @default.
• W1570201758 cites W2119951798 @default.
• W1570201758 cites W2120050284 @default.
• W1570201758 cites W2120754408 @default.
• W1570201758 cites W2121006070 @default.
• W1570201758 cites W2121541993 @default.
• W1570201758 cites W2123147266 @default.
• W1570201758 cites W2125697955 @default.
• W1570201758 cites W2125716797 @default.
• W1570201758 cites W2134121704 @default.
• W1570201758 cites W2141469367 @default.
• W1570201758 cites W2144552468 @default.
• W1570201758 cites W2145730780 @default.
• W1570201758 cites W2146743728 @default.
• W1570201758 cites W2147669684 @default.
• W1570201758 cites W2151857625 @default.
• W1570201758 cites W2156365086 @default.
• W1570201758 cites W2160631086 @default.
• W1570201758 cites W2164466909 @default.
• W1570201758 cites W2165441306 @default.
• W1570201758 cites W2165806143 @default.
• W1570201758 cites W2166050325 @default.
• W1570201758 cites W2169387542 @default.
• W1570201758 cites W2171293694 @default.
• W1570201758 cites W4212782061 @default.
• W1570201758 cites W4292948591 @default.
• W1570201758 cites W49868072 @default.
• W1570201758 cites W61470613 @default.
• W1570201758 cites W69657856 @default.
• W1570201758 cites W94151645 @default.
• W1570201758 cites W2038215322 @default.
• W1570201758 doi "https://doi.org/10.1111/j.1540-8183.2011.00628.x" @default.
• W1570201758 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21443551" @default.
• W1570201758 hasPublicationYear "2011" @default.
• W1570201758 type Work @default.
• W1570201758 sameAs 1570201758 @default.
• W1570201758 citedByCount "10" @default.
• W1570201758 countsByYear W15702017582012 @default.

• next